ArticleFrontiers in oncology2022

Development of a Prognostic Alternative Splicing Signature Associated With Tumor Microenvironment Immune Profiles in Lung Adenocarcinoma.

Guangyao Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.